Cardiac Amyloidosis: The Importance of a Multidisciplinary Approach

详细信息    查看全文

• 作者：Manuel Gó ; mez-Bueno ; Javier Segovia ; Pablo Garcí ; a-Paví ; a ; Juan M. Barceló ; Isabel Krsnik ; Ví ; ctor Sá ; nchez-Turrió ; n ; Clara Salas ; Luis Alonso-Pulpó ; n
• 关键词：Cardiac amyloidosis ; Restrictive cardiomyopathy ; Heart transplantation
• 刊名：Revista Española de Cardiología (English Edition)
• 出版年：2009
• 出版时间：June 2009
• 年：2009
• 卷：62
• 期：6
• 页码：698-702
• 全文大小：504 K

文摘

Cardiac amyloidosis is associated with the interstitial deposition of abnormal protein in the myocardium, which can lead to a form of restrictive cardiomyopathy with a poor prognosis. This protein can have a number of different origins, which give rise to various subtypes of amyloidosis that have different prognoses and that require different therapeutic approaches. Drugs commonly used in heart failure have little effect in amyloidosis and the use of heart transplantation is controversial because amyloidosis is a multi-organ disease and because there is a possibility of disease recurrence in the graft.

The use of new techniques to identify the specific amyloidosis subtype, the emergence of novel ways of preventing or decreasing amyloid production, the ability to monitor responses to therapy and, above all, the introduction of multidisciplinary teams that can implement a combination of therapies, including multiple organ transplantation, have contributed to a substantial improvement in the prognosis of this disease.